More Abbisko Cayman Limited news
Abbisko Cayman LimitedHKEX: 2256

Next Day Disclosure Returns

Oct 30, 2026 at 6:40 AM EDT · Issued by Abbisko Cayman Limited via HKEXnews

Filed with HKEX · Stock code 2256 · Oct 30, 2026 at 6:40 AM EDT · 7 pages · English

On 6ix: 6ix.com/news/next-day-disclosure-returns-186

Abbisko Cayman Limited on 6ix

Earlier from Abbisko Cayman

  • Voluntary announcement - abbisko therapeutics' lavengratinib (ABSK061) for the treatment of achondroplasia granted Orphan Designation by EMAOct 21

Later from Abbisko Cayman

  • Change of company nameNov 2
  • Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026Nov 2
  • INSIDE INFORMATION - PIMJETMI (pimicotinib) Receive U.S. FDA Approval for TGCTNov 10
  • Voluntary announcement - increase in shareholding of the company by the founder, the executive director, the chief executive officer and the chairman of the board of the companyNov 11
  • VOLUNTARY ANNOUNCEMENT - Abbisko Therapeutics Presents Preclinical Findings on Novel Selective CDK4 Inhibitor ABSK192 in Single-Agent and Combination Studies at 2026 ENANov 18
All Abbisko Cayman news releases↗

Follow Abbisko Cayman into a list and get an email when it puts out news.

Follow Abbisko Cayman
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer